These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9205819)

  • 1. Pharmacokinetic and pharmacodynamic assessment of bioavailability for two prodrugs of methylprednisolone.
    Daley-Yates PT; Gregory AJ; Brooks CD
    Br J Clin Pharmacol; 1997 Jun; 43(6):593-601. PubMed ID: 9205819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma.
    Parker TJ; Daley-Yates PT; Wood SA
    Br J Clin Pharmacol; 1997 Jun; 43(6):589-92. PubMed ID: 9205818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of the pharmacokinetics of methylprednisolone after single and multiple intravenous doses of methylprednisolone sodium succinate and methylprednisolone suleptanate to healthy volunteers.
    Ferry JJ; Della-Coletta AA; Weber DJ; VanderLugt JT
    J Clin Pharmacol; 1994 Nov; 34(11):1109-15. PubMed ID: 7876403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.
    Kong AN; Ludwig EA; Slaughter RL; DiStefano PM; DeMasi J; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):616-28. PubMed ID: 2689044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.
    Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H
    Pharm Res; 1995 Jul; 12(7):1096-100. PubMed ID: 7494809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seventy-two hour comparison of methylprednisolone suleptanate and methylprednisolone sodium succinate in patients with acute asthma.
    Muir JF; Godard PH; Verhaert ; Leophonte P; Racineux JL; Harry JD
    Br J Clin Pract; 1996 Dec; 50(8):440-5. PubMed ID: 9039715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass.
    Kong AN; Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Pharmacotherapy; 1990; 10(1):29-34. PubMed ID: 2179900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.
    Mehvar R; Hoganson DA
    Pharm Res; 2000 Nov; 17(11):1402-7. PubMed ID: 11205734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of methylprednisolone and its sodium succinate prodrug in vivo and in perfused liver of rats: nonlinear and sequential first-pass elimination.
    Kong AN; Jusko WJ
    J Pharm Sci; 1991 May; 80(5):409-15. PubMed ID: 1880717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate inhibitory effect of methylprednisolone suleptanate (U-67590A) on antigen-induced cutaneous and airway anaphylactic responses in guinea-pigs.
    Hashimoto M; Shinozaki Y; Katori M
    Br J Pharmacol; 1993 Mar; 108(3):604-12. PubMed ID: 7682130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man.
    Reiss WG; Slaughter RL; Ludwig EA; Middleton E; Jusko WJ
    J Allergy Clin Immunol; 1990 Jun; 85(6):1058-66. PubMed ID: 2191992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury.
    Barth J; Winkler J; Schumann R; Nagaraja NV; Madabushi R; Balbach S; Derendorf H; Möllmann H; Möllenhoff G
    Int J Clin Pharmacol Ther; 2004 Sep; 42(9):504-11. PubMed ID: 15487809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylprednisolone suleptanate Pharmacia Corp.
    Paggiaro P
    Curr Opin Investig Drugs; 2000 Sep; 1(1):97-103. PubMed ID: 11249603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: plasma and tissue disposition.
    Zhang X; Mehvar R
    J Pharm Sci; 2001 Dec; 90(12):2078-87. PubMed ID: 11745766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics.
    Wald JA; Salazar DE; Chen HY; Jusko WJ
    J Pharmacokinet Biopharm; 1991 Oct; 19(5):521-36. PubMed ID: 1783990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: local immunosuppressive effects in liver after systemic administration to rats.
    Chimalakonda AP; Mehvar R
    Pharm Res; 2003 Feb; 20(2):198-204. PubMed ID: 12636157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.
    Ludwig EA; Kong AN; Camara DS; Jusko WJ
    J Clin Pharmacol; 1993 Sep; 33(9):805-10. PubMed ID: 8227476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation study of the relationship between variation in bioavailability and clinical equivalence using a direct link model.
    Matsumoto Y; Shimizu M; Ogata H
    Int J Clin Pharmacol Ther; 2005 Jan; 43(1):57-62. PubMed ID: 15704616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes.
    Mehvar R; Dann RO; Hoganson DA
    J Control Release; 2000 Jul; 68(1):53-61. PubMed ID: 10884579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone pharmacokinetics after intravenous and oral administration.
    Al-Habet SM; Rogers HJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):285-90. PubMed ID: 2655680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.